C-Rad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

C-Rad şirketinin toplam hissedar öz sermayesi SEK302.7M ve toplam borcu SEK0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla SEK464.8M ve SEK162.1M dir. C-Rad 'in FAVÖK'ü SEK70.7M faiz karşılama oranı -2946.3 dur. Şirketin SEK142.4M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

SEK 0

Borç

Faiz karşılama oranı	-13.8x
Nakit	SEK 118.70m
Eşitlik	SEK 310.20m
Toplam yükümlülükler	SEK 139.90m
Toplam varlıklar	SEK 450.10m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 24C 'nin kısa vadeli varlıkları ( SEK424.2M ) kısa vadeli yükümlülüklerini ( SEK158.1M ) aşıyor.

Uzun Vadeli Yükümlülükler: 24C şirketinin kısa vadeli varlıkları ( SEK424.2M ) uzun vadeli yükümlülüklerini ( SEK4.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 24C borçsuzdur.

Borcun Azaltılması: 24C un 5 yıl önce borcu yoktu.

Borç Kapsamı: 24C un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: 24C şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

C-Rad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter 2024 earnings released: EPS: kr0.45 (vs kr0.32 in 3Q 2023)

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: kr0.31 (vs kr0.16 in 2Q 2023)

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: kr1.05 (vs kr0.22 in FY 2022)

C-Rad AB (publ) Appoints Mats Thorén as Board Member

New minor risk - Share price stability

C-Rad AB (publ) to Report Fiscal Year 2023 Results on Apr 23, 2024

Full year 2023 earnings released: EPS: kr1.36 (vs kr0.22 in FY 2022)

Investor sentiment improves as stock rises 17%

C-Rad AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

Third quarter 2023 earnings released

Investor sentiment improves as stock rises 23%

New major risk - Share price stability

Investor sentiment improves as stock rises 15%

C-Rad AB (Publ) Announces Former Employee Appeals Verdict from the Patent and Market Court of Appeal

New major risk - Earnings quality

C-Rad AB (publ) to Demonstrate Enhancements in Surface Guided Solutions for Advanced Radiotherapy Treatments at AAPM

Second quarter 2023 earnings released

New minor risk - Share price stability

Less than half of directors are independent

Full year 2022 earnings released: EPS: kr0.22 (vs kr0.74 in FY 2021)

Full year 2022 earnings released: EPS: kr0.22 (vs kr0.74 in FY 2021)

C-Rad AB (publ) to Report Fiscal Year 2022 Final Results on Apr 06, 2023

C-Rad AB (Publ) Appoints Christoffer Herou as CFO

C-Rad AB (Publ) Announces CEO Changes

C-Rad AB (publ) Announces CFO Changes

Third quarter 2022 earnings released

C-Rad AB (publ) to Report Fiscal Year 2023 Results on Feb 02, 2024

C-RAD Launches New Updated eDucation Portal as an Online Platform

Second quarter 2022 earnings released

Henrik Bergentoft Resigns as CFO of C-RAD

C-Rad Announces CEO Changes

First quarter 2022 earnings released

Insufficient new directors

Insufficient new directors

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

C-Rad AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

C-Rad Achieves Another Milestone Ensuring the Availability of SGRT, the Standard of Care for Radiotherapy

Third quarter 2021 earnings released

Chief Operating Officer recently sold €61k worth of stock

Second quarter 2021 earnings released

C-Rad AB (publ) Announces The Patent and Market Court Rejected Former Employee Claim for Compensation

The Patent and Market Court of Appeal Issues Judgement Confirming C-Rad's Entitlement to Beamocular's Invention

Full year 2020 earnings released: EPS kr0.43 (vs kr0.45 loss in FY 2019)

C-RAD and Alliance Radiation Oncology Announce That Alliance Has Become the First Center in the Greater Northshore Area to Integrate C-Rad

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin